Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

532 results about "Polyhydroxyalkanoates" patented technology

Polyhydroxyalkanoates or PHAs are polyesters produced in nature by numerous microorganisms, including through bacterial fermentation of sugar or lipids. When produced by bacteria they serve as both a source of energy and as a carbon store. More than 150 different monomers can be combined within this family to give materials with extremely different properties. These plastics are biodegradable and are used in the production of bioplastics.

Medical devices and applications of polyhydroxyalkanoate polymers

Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair / regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats. The polyhydroxyalkanoates can contain additives, be formed of mixtures of monomers or include pendant groups or modifications in their backbones, or can be chemically modified, all to alter the degradation rates. The polyhydroxyalkanoate compositions also provide favorable mechanical properties, biocompatibility, and degradation times within desirable time frames under physiological conditions.
Owner:TEPHA INC

Medical devices and applications of polyhydroxyalkanoate polymers

Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair / regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats. The polyhydroxyalkanoates can contain additives, be formed of mixtures of monomers or include pendant groups or modifications in their backbones, or can be chemically modified, all to alter the degradation rates. The polyhydroxyalkanoate compositions also provide favorable mechanical properties, biocompatibility, and degradation times within desirable time frames under physiological conditions.
Owner:TEPHA INC

Polyhydroxyalkanoates of narrow molecular weight distribution prepared in transgenic plants

Methods for the biosynthesis of polyhydroxyalkanoate homopolymers and copolymers are described. In a preferred embodiment, the polymers have a single mode molecular weight distribution, and more preferably have a distribution of between about 2 and about 4, and most preferably about 2.1 or 2.5.
Owner:METABOLIX

Fibers comprising polyhydroxyalkanoate copolymer/polylactic acid polymer or copolymer blends

Environmentally degradable melt spun fibers comprising a polyhydroxyalkanoate copolymer and a polylactic acid polymer or copolymer are disclosed. A preferred configuration of the present invention is directed to environmentally degradable fibers comprising a sheath / core structure where the core comprises a biodegradable polyhydroxyalkanoate copolymer and the sheath comprises a polymer or copolymer of polylactic acid. Nonwoven webs and disposable articles comprising the environmentally degradable fibers are also disclosed.
Owner:DANIMER IPCO LLC

Polyhydroxyalkanoate compositions having controlled degradation rates

Biocompatible polyhydroxyalkanoate compositions with controlled degradation rates have been developed. In one embodiment, the polyhydroxyalkanoates contain additives to alter the degradation rates. In another embodiment, the polyhydroxyalkanoates are formed of mixtures of monomers or include pendant groups or modifications in their backbones to alter their degradation rates. In still another embodiment, the polyhydroxyalkanoates are chemically modified. Methods for manufacturing the devices which increase porosity or exposed surface area can be used to alter degradability. For example, as demonstrated by the examples, porous polyhydroxyalkanoates can be made using methods that creates pores, voids, or interstitial spacing, such as an emulsion or spray drying technique, or which incorporate leachable or lyophilizable particles within the polymer. Examples describe poly(4HB) compositions including foams, coatings, meshes, and microparticles. As demonstrated by the examples, these polyhydroxyalkanoate compositions have extremely favorable mechanical properties, as well as are biocompatible and degrade within desirable time frames under physioogical conditions. These polyhydroxyalkanoate materials provide a wider range of polyhydroxyalkanoate degradation rates than are currently available. Methods for processing these materials, particularly for therapeutic, prophylactic or diagnostic applications, or into devices which can be implanted or injected, are also described.
Owner:TEPHA INC

Method for making devices using polyhydroxyalkanoate having pyrogen removed

Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided for use in numerous biomedical applications. PHAs which have been chemically modified to enhance physical and / or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and / or solubility in non-toxic solvents, are also described. PHAs are provided which are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone and other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses. Properties which are selected for include degradability, elasticity, inclusion of functional groups or derivatized groups, which can in turn be used to attach targeting agents, and bioadhesion.
Owner:TEPHA INC

Recombinant expressed bioadsorbable polyhydroxyalkonate monofilament and multi-filaments self-retaining sutures

The present invention provides polymers made by genetically engineering microorganisms for making a self-retaining suture. In an embodiment of the present invention the genetically engineering microorganisms synthesize polyhydroxyalkanoate (PHA) polymers. In an alternate embodiment of the invention, the genetically engineering microorganisms synthesize polybetahydroxybutyrate (PHB) polymers. In an alternative embodiment of the invention, the self-retaining sutures can be made from a copolymer such as polyhydroxybutyratevalerate (PHBV), where the genetically engineering microorganisms produces PHA polymers as the monofilament base material and a different genetically engineering microorganisms produces polyhydroxybutyratevalerate (PHBV) polymers. In various embodiments of the invention, recombinant expressed self-retaining suture materials have a melting point in the range from between approximately 40° C. to approximately 180° C. In various embodiments of the invention, recombinant expressed self-retaining suture materials have extension-to-break strength of between approximately 8% and approximately 42%.
Owner:ETHICON INC

Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation

Polyhydroxyalkanoate materials are provided which are suitable for repair of soft tissue, augmentation, and as viscosupplements in animals, particularly humans. The materials comprise liquid polyhydroxyalkanoate polymer compositions or polyhydroxyalkanoate microdispersions. Devices also are provided for storage and delivery of the polyhydroxyalkanoate compositions in vivo. Methods are provided for repairing or augmenting soft tissue in animals using the materials. In a preferred embodiment, the method include the steps of (a) selecting the animal soft tissue to be repaired or augmented; and (b) placing an injectable, liquid polyhydroxyalkanoate polymer or a polyhydroxyalkanoate microdispersion into the animal soft tissue, preferably using a minimally-invasive method such as injection. In another embodiment, the liquid polyhydroxyalkanoate polymer compositions or polyhydroxyalkanoate microdispersions are used as viscosupplements.
Owner:TEPHA INC

Applications of degradable polymers for delayed mechanical changes in wells

Degradable polylactic or polyhydroxyalkanoate polymers may be used to viscosify aqueous fluids for use in wells, Sand control screen or liner can be coated with a solid degradable polymer during placement in a well. Mechanical changes or flow changes in a well can be caused by solid degradable polymer that changes physical properties after it is placed in a well. Parts of devices or entire devices can be made of solid degradable polymer that converts to a fluid after selected times in an aqueous environment in a well.
Owner:COOKE JR CLAUDE E

Polyhydroxyalkanoate medical textiles and fibers

Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate. These devices provide a wider range of in vivo strength retention properties than are currently available, and could offer additional benefits such as anti-adhesion properties, reduced risks of infection or other post-operative problems resulting from absorption and eventual elimination of the device, and competitive cost. The devices may also be particularly suitable for use in pediatric populations where their absorption should not hinder growth, and provide in all patient populations wound healing with long-term mechanical stability. The devices may additionally be combined with autologous, allogenic and / or xenogenic tissues to provide implants with improved mechanical, biological and handling properties.
Owner:TEPHA INC

Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages

Coatings for an implantable medical device and a method of fabricating thereof are disclosed, the coatings including block-polymers comprising at least one poly(hydroxyacid) or poly(hydroxy-alkanoate) block, at least one block of a biologically compatible polymer and at least one type of linking moiety.
Owner:ABBOTT CARDIOVASCULAR

Polyurethanes obtained from hydroxyalkanoates and isocyanates

A polyurethane is described which is a reaction product of at least one isocyanate containing material having at least two isocyanate groups and at least one compound having at least two hydrogen atoms capable of reacting with the isocyanate. The compound having the at least two hydrogen atoms contains a hydroxyalkanoate, which is preferably a thermally decomposable or a biodegradable polyhydroxyalkanoate. The polyurethane of the present invention can be used in a number of applications and preferably has improved properties such as, but not limited to, improved flexibility and / or improved hydrophobicity. The polyurethanes of the present invention are preferably biodegradable and easily recycled.
Owner:METABOLIX

Molded or extruded articles comprising polyhydroxyalkanoate copolymer and an environmentally degradable thermoplastic polymer

Environmentally degradable molded or extruded articles comprising a blend of polyhydroxyalkanoate copolymer and an environmentally degradable thermoplastic polymer or copolymer are disclosed. Such compositions provide annealing cycle times to form molded or extruded articles that are less than annealing cycle times to form a molded or extruded article lacking the environmentally degradable thermoplastic polymer or copolymer.
Owner:DANIMER IPCO LLC

Absorbent article comprising a synthetic polymer derived from a renewable resource and methods of producing said article

An element of an absorbent article is provided. The element has a bio-based content of at least about 50% based on the total weight of the element, and comprises a synthetic polymer derived from a renewable resource via a first intermediate compound selected from the group consisting of crotonic acid, propiolactone, ethylene oxide, i-propanol, butanol, butyric acid, propionic acid, 2-acetoxypropanoic acid, methyl 2-acetoxypropanoate, methyl lactate, ethyl lactate, polyhydroxybutyrate, and a polyhydroxyalkanoate comprising 3-hydroxypropionate monomers. An absorbent article comprising the element and a method of making an element for an absorbent article also are provided.
Owner:THE PROCTER & GAMBLE COMPANY

Polyhydroxyalkanoate copolymer/starch compositions for laminates and films

Films comprising a blend of polyhydroxyalkanoate copolymer and destructured starch are disclosed. Laminates having a first layer comprising a PHA copolymer and a second layer comprising a PHA copolymer / starch blend or thermoplastic starch are also disclosed. Disposable articles comprising the environmentally degradable films or laminates are also disclosed.
Owner:DANIMER IPCO LLC

Slow-release fertilizer with effect of soil remediation and remediation method of soil polluted by polycyclic aromatic hydrocarbons

The invention discloses slow-release fertilizer with the effect of soil remediation, which is prepared by polyhydroxyalkanoates which can be completely biodegraded, organic and inorganic nutrients and other substances, by slow-releasing the organic and inorganic nutrients, microorganism propagation and sustained and rapid growth of plants can be promoted, the bioactivity and water solubility of polycyclic aromatic hydrocarbons are quickened, and simultaneously, the defects of fertilizer loss and repeated fertilization can be avoided, thereby saving the cost and enhancing the soil remediation efficiency. The invention also discloses a soil pollution remediation method by utilizing the slow-release fertilizer, plants with the remediation effect are planted in the soil with the slow-release fertilizer, and efficient, environment-friendly and sustained remediation of the soil polluted by the polycyclic aromatic hydrocarbons (PAHs) can be realized by utilizing the microorganism-plant remediation technology.
Owner:SHENZHEN ECOMANN BIOTECH

Methods and devices for rotator cuff repair

Interposition and augmentation devices for tendon and ligament repair, including rotator cuff repair, have been developed as well as methods for their delivery using arthroscopic methods. The devices are preferably derived from biocompatible polyhydroxyalkanoates, and preferably from copolymers or homopolymers of 4-hydroxybutyrate. The devices may be delivered arthroscopically, and offer additional benefits such as support for the surgical repair, high initial strength, prolonged strength retention in vivo, flexibility, anti-adhesion properties, improved biocompatibility, an ability to remodel in vivo to healthy tissue, minimal risk for disease transmission or to potentiate infection, options for fixation including sufficiently high strength to prevent suture pull out or other detachment of the implanted device, eventual absorption eliminating future risk of foreign body reactions or interference with subsequent procedures, competitive cost, and long-term mechanical stability. The devices are also particularly suitable for use in pediatric populations where their eventual absorption should not hinder growth.
Owner:TEPHA INC

Polyhydroxyalkanoate production method

ActiveUS20130337516A1Reduce carbon input costWide availabilityFermentationCarbon sourceMaterials science
Provided are processes for the production and high efficiency processing of polyhydroxyalkanoates (PHA) from carbon sources comprising carbon-containing gases or materials.
Owner:NEWLIGHT TECH

Green process and compositions for producing poly(5HV) and 5 carbon chemicals

Recombinant hosts for producing polyhydroxyalkanoates and methods of producing polyhydroxyalkanoates from renewable carbon substrates are provided. Certain recombinant hosts that produce 5 carbon chemicals such as 5-aminopentanoate (5AP), 5-hydroxyvalerate (5HV), glutarate, and 1,5 pentanediol (PDO) are also provided. One embodiment provides a recombinant host expressing a gene encoding a heterologous enzyme selected from the group consisting of a polyhydroxyalkanoate synthase and a 5-hydroxyvalerate-CoA (5HV-CoA) transferase, wherein the host produces a polymer containing 5-hydroxyvalerate. Preferably, the host expresses both a polyhydroxyalkanoate synthase and a 5HV-CoA transferase. The host can be prokaryotic or eukaryotic. A preferred prokaryotic host is E. coli. The polymers produced by the recombinant hosts can be homopolymers or copolymers of 5-hydroxyvalerate. A preferred copolymer is poly(3-hydroxybutyrate-co-5-hydroxyvalerate).
Owner:CJ CHEILJEDANG CORP

Recombinant cell producing 2-hydroxyisobutyric acid

ActiveUS20110171702A1Less stressfulFew stepsMicroorganismsFermentationAcetoacetyl coenzyme AWild type
The invention relates to a cell which has been genetically modified so as to be capable of producing more 2-hydroxyisobutyric acid or more polyhydroxyalkanoates containing 2-hydroxyisobutyric acid monomer units than its wild type, characterized in that 2-hydroxyisobutyric acid or polyhydroxyalkanoates containing 2-hydroxyisobutyric acid monomer units are produced via acetoacetyl-coenzyme A as intermediate and 3-hydroxybutyryl-coenzyme A as precursor.
Owner:ROHM GMBH

Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from

InactiveUS20080057128A1Interesting propertyVivo degradation ratePowder deliveryPeptide/protein ingredientsPolymer scienceSynthesis methods
A drug delivery system that includes micelles formed from an amphiphilic copolymer that includes an A polymer block comprising a poly(alkylene oxide) and a B polymer block comprising a poly(hydroxyalkanoate), and a therapeutically effective amount of at least one therapeutic agent intimately contained within the micelles. In one preferred embodiment of the invention, the A polymer block is poly(ethylene oxide) (PEO) and the B polymer block is poly[(R)-3-hydroxybutyrate] (PHB), and the copolymer is the triblock ABA copolymer PEO-PHB-PEO. A method of synthesizing the amphiphilic triblock copolymer is also provided.
Owner:OMEROS CORP

Use of selection pressures to enable microbial biosynthesis of polyhydroxyalkanoates from anaerobic degradation products

A method for inexpensive and efficient PHA biosynthesis includes operating a sequencing bioreactor in alternating phases of nutrient deprivation and carbon feedstock deprivation to select for robust PHA-producing microbes. Preferably, the bioreactor is operated in a non-sterile manner with mixed cultures of methanotrophs. The method also preferably uses periodic biomass-wasting (PHA harvesting) at the end of the carbon feed phase, gradually lengthening the time period of carbon deprivation phase to create a penalty for rapid PHA degradation and incentive for PHA accumulation. Also, bacterial enrichment cultures may be introduced periodically. The PHA-accumulating bacteria are preferably grown on common anaerobic degradation products, specifically volatile fatty acids, such as acetate and propionate, and methane gas. The PHA has useful applications in bioplastics and other products.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Slow release fertilizer having soil remediation function and soil contamination remediation method

The invention discloses a slow release fertilizer having a soil remediation function. The slow release fertilizer is prepared by mixing fully-biodegradable polyhydroxyalkanoates and organic and inorganic nutrient substances. The fully-biodegradable polyhydroxyalkanoates is slowly degraded under the actions of soil microorganisms to provide nutrient substances needed by the growth of the soil microorganisms so as to promote the ionization effects of the soil microorganisms on heavy metals and release the organic and inorganic nutrient substances by slow degradation so as to promote durable and rapid growth of plants and improve soil remediation efficiency. The invention also discloses a soil contamination remediation method for using the slow release fertilizer. High-efficiency, environmentally-friendly and durable remediation of heavy metal-contaminated soil is realized by planting plants having hyper-accumulation capability to absorb and extract the heavy metals in the soil to which the slow release fertilizer is applied.
Owner:SHENZHEN ECOMANN BIOTECH

Polyhydroxyalkanoate, its production method, charge control agent containing the polyhydroxyalkanoate, toner binder and toner, and image forming method and image forming apparatus using the toner

The present invention provides a novel PHA comprising a unit containing thioether with high reactivity, and its production method. The present invention also provides polyhydroxyalkanoate (PHA) comprising units having defined chemical formulas (1) and (2), and at least one of four units having defined chemical formulas (3), (4), (5) and (6); its production method; a charge control agent containing the PHA; a toner binder containing the charge control agent; an electrostatic latent image developing toner; and an image forming method and an image forming apparatus using the electrostatic latent image developing toner.
Owner:CANON KK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products